Francois Cedric

Insider CIK 1658080 · APLS Chief Executive Officer, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	170,400	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	131,093	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	150,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	206,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	104,834	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	273,312	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	287,500	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	273,779	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	100,538	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	20,862	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	97,976	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	97,976	—	$0	97,976	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	87,108	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	87,108	—	$0	87,108	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	143,750	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	143,750	—	$0	143,750	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	234,411	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	300,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	472,065	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	372,815	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	425,968	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	195,952	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	97,997	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	36,047	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	195,952	—	$0	195,952	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	195,952	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2026-03-11	2026-03-13	64,869	—	$0	372,815	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2026-03-11	2026-03-13	64,869	—	$0	425,968	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2026-02-03	2026-02-05	8,840	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2026-02-03	2026-02-05	8,840	$3.76	$33.2K	490,837	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-01-28	2026-01-30	195,952	—	$0	481,997	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-22	2026-01-23	27,192	$21.77	$592.0K	286,045	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-20	2026-01-21	8,182	$19.79	$161.9K	313,237	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-13	2026-01-15	10,186	$22.19	$226.0K	321,419	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-08-28	2025-08-29	49,963	$28.39	$1.42M	307,946	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-08-27	2025-08-29	175,037	$28.19	$4.93M	357,909	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2025-07-17	2025-07-18	8,997	—	$0	100,538	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-07-17	2025-07-18	19,725	$20.21	$398.6K	331,605	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2025-07-17	2025-07-18	8,997	$4.31	$38.8K	351,330	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2025-07-15	2025-07-16	800	—	$0	109,535	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-07-15	2025-07-16	1,900	$20.09	$38.2K	342,333	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2025-07-15	2025-07-16	800	$4.31	$3.4K	344,233	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2025-07-14	2025-07-16	65,203	—	$0	110,335	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-07-14	2025-07-16	137,465	$20.19	$2.78M	343,433	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2025-07-14	2025-07-16	65,203	$4.31	$281.0K	480,898	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2025-06-09	2025-06-11	287,500	$19.39	$5.57M	287,500	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-29	2025-01-30	2,824	$29.52	$83.4K	415,695	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-22	2025-01-23	13,551	$30.43	$412.4K	418,519	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2025-01-21	2025-01-21	130,662	—	$0	432,070	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-17	2025-01-21	6,007	$29.96	$180.0K	301,408	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-13	2025-01-14	6,247	$28.70	$179.3K	307,415	SEC↗
APLS Apellis Pharmaceuticals, I	J Other	2024-11-01	2024-11-01	182,146	—	$0	472,065	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2024-03-01	2024-03-05	50,000	—	$0	8,840	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2024-03-01	2024-03-05	200,000	—	$0	175,538	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2024-03-01	2024-03-05	50,000	$3.76	$188.0K	363,662	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2024-03-01	2024-03-05	200,000	$4.31	$862.0K	563,662	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-01	2024-03-05	28,868	$62.21	$1.80M	534,794	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-01	2024-03-05	41,704	$62.96	$2.63M	493,090	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-01	2024-03-05	62,503	$64.26	$4.02M	430,587	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-01	2024-03-05	116,512	$64.92	$7.56M	314,075	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-01	2024-03-05	413	$65.68	$27.1K	313,662	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-02-12	2024-02-13	3,962	$67.77	$268.5K	313,662	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-29	2024-01-31	2,843	$64.14	$182.4K	317,624	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-22	2024-01-23	13,431	$65.00	$873.0K	320,467	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2024-01-16	2024-01-17	104,834	$66.30	$6.95M	104,834	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2024-01-16	2024-01-17	72,094	—	$0	341,749	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-16	2024-01-17	7,851	$66.81	$524.5K	333,898	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-11-21	2023-11-21	5,000	$48.80	$244.0K	269,655	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-09-19	2023-09-20	150,000	—	$0	804,211	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-09-19	2023-09-20	150,000	—	$0	274,655	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-09-01	2023-09-01	300,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-09-01	2023-09-01	139,716	$41.70	$5.83M	434,939	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-09-01	2023-09-01	300,000	$2.67	$801.0K	574,655	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-09-01	2023-09-01	10,284	$42.44	$436.5K	424,655	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-05-24	2023-05-25	20,000	—	$0	654,211	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-05-24	2023-05-25	20,000	—	$0	274,655	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-05-17	2023-05-18	20,000	—	$0	300,000	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-05-17	2023-05-18	20,000	$2.67	$53.4K	294,655	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-05-16	2023-05-18	30,000	—	$0	320,000	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-05-16	2023-05-18	7,528	$87.02	$655.1K	276,775	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-05-16	2023-05-18	30,000	$2.67	$80.1K	304,655	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-05-16	2023-05-18	934	$83.17	$77.7K	303,721	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-05-16	2023-05-18	2,120	$87.67	$185.9K	274,655	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-05-16	2023-05-18	3,007	$85.90	$258.3K	284,303	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-05-16	2023-05-18	14,611	$85.01	$1.24M	287,310	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-05-16	2023-05-18	1,800	$83.85	$150.9K	301,921	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-27	2023-04-28	382,946	—	$0	274,655	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-27	2023-04-28	382,946	—	$0	382,946	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-04-19	2023-04-20	20,000	—	$0	350,000	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-04-19	2023-04-20	20,000	$2.67	$53.4K	657,601	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-04-18	2023-04-20	30,000	—	$0	370,000	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-04-18	2023-04-20	30,000	$82.02	$2.46M	637,601	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-04-18	2023-04-20	30,000	$2.67	$80.1K	667,601	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-05	2023-04-05	26,990	—	$0	634,211	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-05	2023-04-05	26,990	—	$0	637,601	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-04	2023-04-05	380,000	—	$0	607,221	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-04	2023-04-05	380,000	—	$0	664,591	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-03	2023-04-05	227,221	—	$0	227,221	SEC↗
APLS Apellis Pharmaceuticals, I	G Gift	2023-04-03	2023-04-05	227,221	—	$0	1,044,591	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-03-22	2023-03-23	7,221	—	$0	273,779	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-03-22	2023-03-23	100,000	—	$0	58,840	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-03-22	2023-03-23	20,000	—	$0	400,000	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-03-22	2023-03-23	7,221	$13.85	$100.0K	1,271,812	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-03-22	2023-03-23	20,000	$2.67	$53.4K	1,164,591	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-03-22	2023-03-23	100,000	$3.76	$376.0K	1,264,591	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-03-21	2023-03-23	30,000	—	$0	420,000	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-03-21	2023-03-23	30,000	$62.74	$1.88M	1,144,591	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-03-21	2023-03-23	30,000	$2.67	$80.1K	1,174,591	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-02-27	2023-03-01	100,000	—	$0	158,840	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-02-27	2023-03-01	100,000	$3.76	$376.0K	1,144,591	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-02-21	2023-02-22	19,728	—	$0	19,728	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-02-21	2023-02-22	13,908	—	$0	1,046,193	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-02-21	2023-02-22	1,602	$58.50	$93.7K	1,044,591	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-02-10	2023-02-14	3,958	$51.21	$202.7K	1,032,285	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-01-27	2023-01-30	2,879	$52.77	$151.9K	1,036,243	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-01-20	2023-01-24	9,453	$52.05	$492.0K	1,039,122	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-01-12	2023-01-17	131,093	$52.66	$6.90M	131,093	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-01-12	2023-01-17	83,447	—	$0	1,048,575	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-12-19	2022-12-21	28,200	—	$0	450,000	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-12-19	2022-12-21	15,000	—	$0	258,840	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-12-19	2022-12-21	6,688	—	$0	273,312	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-12-19	2022-12-21	15,000	$3.76	$56.4K	986,640	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-12-19	2022-12-21	3,751	$51.97	$194.9K	989,577	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-12-19	2022-12-21	6,688	$14.95	$100.0K	993,328	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-12-19	2022-12-21	24,449	$52.07	$1.27M	965,128	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-12-19	2022-12-21	28,200	$2.67	$75.3K	971,640	SEC↗
APLS Apellis Pharmaceuticals, I	J Other deriv	2022-04-25	2023-01-17	75,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	J Other	2022-04-25	2022-12-21	12,500	—	$0	943,440	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2022-02-10	2022-02-14	2,523	$47.12	$118.9K	955,940	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2022-01-28	2022-02-01	2,024	$38.59	$78.1K	1,338,463	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2022-01-21	2022-01-25	150,672	—	$0	150,672	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2022-01-21	2022-01-25	106,244	—	$0	1,340,487	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-07-21	2021-07-22	14,410	—	$0	375,538	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-07-21	2021-07-22	14,410	$4.31	$62.1K	1,234,243	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2021-02-10	2021-02-11	2,523	$47.72	$120.4K	1,219,833	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2021-01-28	2021-02-01	75,000	—	$0	75,000	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2021-01-28	2021-02-01	150,000	—	$0	150,000	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2021-01-28	2021-02-01	25,000	—	$0	1,209,856	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2021-01-28	2021-02-01	12,500	—	$0	1,222,356	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-01-27	2021-01-29	39,785	—	$0	273,840	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-01-27	2021-01-29	31,992	—	$0	389,948	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-01-27	2021-01-29	39,785	$3.76	$149.6K	1,152,864	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-01-27	2021-01-29	31,992	$4.31	$137.9K	1,184,856	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-15	2020-12-16	5,000	$52.16	$260.8K	1,113,079	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-12-01	2020-12-02	40,000	—	$0	313,625	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-12-01	2020-12-02	40,000	$3.76	$150.4K	1,118,079	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-11-16	2020-11-17	5,000	$39.38	$196.9K	1,078,079	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-10-15	2020-10-16	5,000	$34.46	$172.3K	1,083,079	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-09-15	2020-09-16	5,000	$30.96	$154.8K	1,088,079	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-08-20	2020-08-21	3,457	$30.00	$103.7K	1,093,079	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-08-18	2020-08-20	1,543	$30.00	$46.3K	1,096,536	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-07-15	2020-07-16	5,000	$32.12	$160.6K	1,098,079	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-06-15	2020-06-16	5,000	$30.21	$151.1K	1,103,079	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-05-15	2020-05-19	5,000	$29.92	$149.6K	1,108,079	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-04-15	2020-04-17	5,000	$29.77	$148.8K	1,113,079	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-03-17	2020-03-18	30,637	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-03-17	2020-03-18	30,637	$2.14	$65.6K	1,083,704	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-03-16	2020-03-18	30,637	—	$0	30,637	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-03-16	2020-03-18	3,212	$22.28	$71.6K	1,053,367	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-03-16	2020-03-18	300	$23.86	$7.2K	1,053,067	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-03-16	2020-03-18	15,065	$21.58	$325.1K	1,056,579	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-03-16	2020-03-18	2,192	$21.57	$47.3K	1,084,404	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-03-16	2020-03-18	2,108	$20.73	$43.7K	1,086,596	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-03-16	2020-03-18	30,637	$2.14	$65.6K	1,088,704	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-03-16	2020-03-18	700	$22.29	$15.6K	1,083,704	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-03-16	2020-03-18	12,060	$20.69	$249.5K	1,071,644	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-02-19	2020-02-20	30,637	—	$0	61,274	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-02-19	2020-02-20	30,637	$2.14	$65.6K	1,058,067	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-02-18	2020-02-20	30,637	—	$0	91,911	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-02-18	2020-02-20	30,637	$2.14	$65.6K	1,063,067	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-02-18	2020-02-20	5,000	$40.67	$203.3K	1,027,430	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-02-18	2020-02-20	30,637	$40.66	$1.25M	1,032,430	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2020-02-10	2020-02-12	206,250	—	$0	206,250	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2020-02-10	2020-02-12	34,375	—	$0	1,066,805	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-01-16	2020-01-21	30,637	—	$0	122,548	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-01-16	2020-01-21	30,637	$2.14	$65.6K	1,032,430	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-01-15	2020-01-17	30,638	—	$0	153,185	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-01-15	2020-01-17	4,562	$42.55	$194.1K	1,006,793	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-01-15	2020-01-17	26,076	$42.16	$1.10M	1,011,355	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-01-15	2020-01-17	5,000	$41.47	$207.3K	1,001,793	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-01-15	2020-01-17	30,638	$2.14	$65.6K	1,001,793	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-12-16	2019-12-17	5,000	$27.95	$139.8K	1,006,793	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-11-15	2019-11-18	5,000	$27.28	$136.4K	1,011,793	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-10-15	2019-10-16	3,524	$26.61	$93.8K	1,016,793	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-10-15	2019-10-16	1,476	$25.59	$37.8K	1,020,317	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-09-16	2019-09-17	4,740	$26.56	$125.9K	1,022,053	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-09-16	2019-09-17	260	$27.17	$7.1K	1,021,793	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2019-08-23	2019-08-26	37,505	—	$0	478,200	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2019-08-23	2019-08-26	37,505	$2.67	$100.1K	1,026,793	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2019-08-15	2019-08-16	10,000	—	$0	183,823	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2019-08-15	2019-08-16	10,000	$2.14	$21.4K	999,288	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-08-15	2019-08-16	7,754	$26.74	$207.3K	991,534	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2019-08-15	2019-08-16	2,246	$27.00	$60.6K	989,288	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2019-06-27	2019-07-01	275,000	—	$0	193,823	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2019-06-27	2019-07-01	275,000	$2.14	$588.5K	989,288	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2019-02-08	2019-02-12	281,000	—	$0	281,000	SEC↗
APLS Apellis Pharmaceuticals, I	J Other	2018-05-07	2018-05-09	384,292	—	$0	714,288	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2018-02-16	2018-02-21	280,000	—	$0	280,000	SEC↗